Share Twitter LinkedIn Facebook Email Hagop M. Kantarjian, MD of MD Anderson Cancer Center discusses how veno occlusive disease may cause complications while using inotuzumab if not identitified in adult acute lymphoblastic leukemia patients.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read